Should You Buy Giant Biogene Holding Co., Ltd. (HKG:2367) For Its Upcoming Dividend?

Simply Wall St.05-28

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Giant Biogene Holding Co., Ltd. (HKG:2367) is about to go ex...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2638634226?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","is_english":true,"pubTime":"2026-05-28 06:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2638634226","market":"hk","top_or_hot":-1,"title":"Should You Buy Giant Biogene Holding Co., Ltd. (HKG:2367) For Its Upcoming Dividend?","media":"Simply Wall St.","content":"<div>\n<p>Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Giant Biogene Holding Co., Ltd. (HKG:2367) is about to go ex...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/should-you-buy-giant-biogene-holding-co-ltd-hkg2367-for-its\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Should You Buy Giant Biogene Holding Co., Ltd. (HKG:2367) For Its Upcoming Dividend?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShould You Buy Giant Biogene Holding Co., Ltd. (HKG:2367) For Its Upcoming Dividend?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-28 06:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/should-you-buy-giant-biogene-holding-co-ltd-hkg2367-for-its><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Giant Biogene Holding Co., Ltd. (HKG:2367) is about to go ex...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/should-you-buy-giant-biogene-holding-co-ltd-hkg2367-for-its\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2488822045.USD","symbol_name":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/should-you-buy-giant-biogene-holding-co-ltd-hkg2367-for-its","article_id":"2638634226","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/should-you-buy-giant-biogene-holding-co-ltd-hkg2367-for-its","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2638634226","pubTimestamp":1779920722,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK4588":"碎股","SG9999004311.SGD":"Nikko AM Shenton Emerging Enterprise Discovery Fund SGD","BK1207":"个人用品","BK4585":"ETF&股票定投概念","VIG":"股利增长指数ETF-Vanguard","02367":"巨子生物"},"translate_title":"您是否应该购买Giant Biogene Holding Co., Ltd.（HKG：2367）即将派发的股息？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VIG":0.9,"02367":1.5},"content_text":"Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Giant Biogene Holding Co., Ltd. (HKG:2367) is about to go ex-dividend in just 4 days.   The ex-dividend date generally occurs two days before the record date, which is the day on which shareholders need to be on the company's books in order to receive a dividend.  The ex-dividend date is of consequence because whenever a stock is bought or sold, the trade can take two business days or more to settle.    Therefore, if you purchase Giant Biogene Holding's shares on or after the 1st of June, you won't be eligible to receive the dividend, when it is paid on the 25th of June.   The company's next dividend payment will be CN¥1.2104 per share, on the back of last year when the company paid a total of CN¥1.21 to shareholders.  Last year's total dividend payments show that Giant Biogene Holding has a trailing yield of 5.0% on the current share price of HK$27.82.    We love seeing companies pay a dividend, but it's also important to be sure that laying the golden eggs isn't going to kill our golden goose!  So we need to investigate whether Giant Biogene Holding can afford its dividend, and if the dividend could grow. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut.   Fortunately Giant Biogene Holding's payout ratio is modest, at just 29% of profit.     Yet cash flow is typically more important than profit for assessing dividend sustainability, so we should always check if the company generated enough cash to afford its dividend.     Fortunately, it paid out only 48% of its free cash flow in the past year.      It's positive to see that Giant Biogene Holding's dividend is covered by both profits and cash flow, since this is generally a sign that the dividend is sustainable, and a lower payout ratio usually suggests a greater margin of safety before the dividend gets cut.   View our latest analysis for Giant Biogene Holding   Click here to see the company's payout ratio, plus analyst estimates of its future dividends. SEHK:2367 Historic Dividend May 27th 2026 AdvertisementHave Earnings And Dividends Been Growing? Stocks in companies that generate sustainable earnings growth often make the best dividend prospects, as it is easier to lift the dividend when earnings are rising.   If earnings decline and the company is forced to cut its dividend, investors could watch the value of their investment go up in smoke.     For this reason, we're glad to see Giant Biogene Holding's earnings per share have risen 17% per annum over the last five years.        The company has managed to grow earnings at a rapid rate, while reinvesting most of the profits within the business.  This will make it easier to fund future growth efforts and we think this is an attractive combination - plus the dividend can always be increased later.      Giant Biogene Holding also issued more than 5% of its market cap in new stock during the past year, which we feel is likely to hurt its dividend prospects in the long run.  Trying to grow the dividend while issuing large amounts of new shares reminds us of the ancient Greek tale of Sisyphus - perpetually pushing a boulder uphill.   Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth.     Giant Biogene Holding has delivered 66% dividend growth per year on average over the past two years.      Both per-share earnings and dividends have both been growing rapidly in recent times, which is great to see.    Final Takeaway  Is Giant Biogene Holding an attractive dividend stock, or better left on the shelf?       We love that Giant Biogene Holding is growing earnings per share while simultaneously paying out a low percentage of both its earnings and cash flow. These characteristics suggest the company is reinvesting in growing its business, while the conservative payout ratio also implies a reduced risk of the dividend being cut in the future.         Overall we think this is an attractive combination and worthy of further research.    On that note, you'll want to research what risks Giant Biogene Holding is facing.     Be aware that Giant Biogene Holding is showing 2 warning signs in our investment analysis, and 1 of those is a bit unpleasant...    A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks. New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2638634226","isCrawlerRequest":true}